Skip to main content

Advertisement

SpringerLink
Log in

Sequential use of antiresorptives in younger women

  • Letter
  • Published:
Osteoporosis International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kanis JA, McCloskey EV, Johansson H, Cooper C, Rizzoli R, Reginster JY, Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF) (2013) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 24:23–57

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  2. Baró-Mariné F et al (2012) Osteoporosis. http://www.aeem.es/UserFiles/Media/MENOGUIAOSTEOPOROSIS.pdf. Accessed 6 May 2013

  3. Cuzick J, Sestak I, Bonanni B, Costantino JP, Cummings S, DeCensi A, for the SERM Chemoprevention of Breast Cancer Overview Group et al (2013) Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data. Lancet 381(9880):1827–1834. doi:10.1016/S0140-6736(13)60140-3

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  4. Anderson RN, Smith BL (2005) Deaths: leading causes for 2002. Natl Vital Stat Rep 53:1–89

    PubMed  Google Scholar 

  5. Kanis JA, Borgström F, Johnell O, Oden A, Sykes D, Jönsson B (2005) Cost-effectiveness of raloxifene in the UK: an economic evaluation based on the MORE study. Osteoporos Int 16:15–25

    Article  CAS  PubMed  Google Scholar 

  6. Collins P, Mosca L, Geiger MJ, Grady D, Kornitzer M, Amewou-Atisso MG et al (2009) Effects of the selective estrogen receptor modulator raloxifene on coronary outcomes in the raloxifene use for the heart trial: results of subgroup analyses by age and other factors. Circulation 119:922–930

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  7. Oger E (2000) Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBP study group. Groupe d'Etude de la Thrombose de Bretagne Occidentale. Thromb Haemost 83:657–660

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hospital Universitario Dr. Peset, University of Valencia, Av Gaspar Aguilar, 90, 46017, Valencia, Spain

    A. Cano

  2. Department of Obstetrics and Gynecology, University of Granada, Granada, Spain

    N. Mendoza

  3. Clínica de Atención a la Mujer, DIATROS, Barcelona, Spain

    R. Sánchez-Borrego

  4. Department of Pediatrics, Obstetrics and Gynecology, Facultad de Medicina, University of Valencia, Av Blasco Ibáñez 15, 46010, Valencia, Spain

    A. Cano

Authors
  1. A. Cano
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N. Mendoza
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. Sánchez-Borrego
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

for the Osteoporosis Guideline Writing Group from the Spanish Menopause Society

Corresponding author

Correspondence to A. Cano.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cano, A., Mendoza, N., Sánchez-Borrego, R. et al. Sequential use of antiresorptives in younger women. Osteoporos Int 25, 1191–1192 (2014). https://doi.org/10.1007/s00198-013-2436-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-013-2436-0

Keywords

Search

Navigation